Celgene Income Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 1,405.8 | 898.9 | 536.9 |
| Cost of Goods Sold | 130.2 | 125.9 | 80.7 |
| Gross Profit | 1,275.6 | 773.0 | 456.2 |
| Gross Profit Margin | 90.7% | 86.0% | 85.0% |
| SG&A Expense | 819.6 | 573.2 | 354.1 |
| Depreciation & Amortization | 30.9 | 25.1 | 18.5 |
| Operating Income | 425.1 | 174.7 | 83.6 |
| Operating Margin | 30.2% | 19.4% | 15.6% |
| Nonoperating Income | 107.5 | 45.8 | 10.1 |
| Nonoperating Expenses | 11.1 | 9.4 | 9.5 |
| Income Before Taxes | 517.0 | 202.9 | 84.2 |
| Income Taxes | 290.5 | 133.9 | 20.6 |
| Net Income After Taxes | 226.4 | 69.0 | 63.6 |
| Continuing Operations | 226.4 | 69.0 | 63.7 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 226.4 | 69.0 | 63.7 |
| Total Net Income | 226.4 | 69.0 | 63.7 |
| Net Profit Margin | 16.1% | 7.7% | 11.9% |
| Diluted EPS from Total Net Income ($) | 0.54 | 0.18 | 0.18 |
| Dividends per Share | -- | -- | -- |





